NO20010089L - Farmasöytisk levotyroksinpreparat - Google Patents
Farmasöytisk levotyroksinpreparatInfo
- Publication number
- NO20010089L NO20010089L NO20010089A NO20010089A NO20010089L NO 20010089 L NO20010089 L NO 20010089L NO 20010089 A NO20010089 A NO 20010089A NO 20010089 A NO20010089 A NO 20010089A NO 20010089 L NO20010089 L NO 20010089L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- pharmaceutical
- pharmaceutical levothyroxine
- levothyroxine preparation
- excipients
- Prior art date
Links
- XUIIKFGFIJCVMT-LBPRGKRZSA-N L-thyroxine Chemical compound IC1=CC(C[C@H]([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-LBPRGKRZSA-N 0.000 title abstract 2
- 229950008325 levothyroxine Drugs 0.000 title 1
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 title 1
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 abstract 3
- 229920000168 Microcrystalline cellulose Polymers 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 239000011230 binding agent Substances 0.000 abstract 1
- 229960003918 levothyroxine sodium Drugs 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 abstract 1
- 239000008108 microcrystalline cellulose Substances 0.000 abstract 1
- 229940016286 microcrystalline cellulose Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 229960004839 potassium iodide Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/18—Iodine; Compounds thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19830246A DE19830246A1 (de) | 1998-07-07 | 1998-07-07 | Pharmazeutische Zubereitung |
| PCT/EP1999/004485 WO2000002586A1 (de) | 1998-07-07 | 1999-06-29 | Pharmazeutische levothyroxinzubereitung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20010089D0 NO20010089D0 (no) | 2001-01-05 |
| NO20010089L true NO20010089L (no) | 2001-01-05 |
Family
ID=7873182
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20010089A NO20010089L (no) | 1998-07-07 | 2001-01-05 | Farmasöytisk levotyroksinpreparat |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6491946B1 (cs) |
| EP (1) | EP1094841B1 (cs) |
| JP (1) | JP2002520296A (cs) |
| KR (1) | KR20010071765A (cs) |
| CN (1) | CN1307486A (cs) |
| AR (1) | AR019899A1 (cs) |
| AT (1) | ATE273697T1 (cs) |
| AU (1) | AU751575B2 (cs) |
| BR (1) | BR9911884A (cs) |
| CA (1) | CA2336748A1 (cs) |
| CZ (1) | CZ296897B6 (cs) |
| DE (2) | DE19830246A1 (cs) |
| HU (1) | HUP0104985A3 (cs) |
| ID (1) | ID27150A (cs) |
| NO (1) | NO20010089L (cs) |
| PL (1) | PL344834A1 (cs) |
| SK (1) | SK20042000A3 (cs) |
| WO (1) | WO2000002586A1 (cs) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19821625C1 (de) * | 1998-05-15 | 2000-01-05 | Merck Patent Gmbh | Pharmazeutische Zubereitung |
| US9522217B2 (en) | 2000-03-15 | 2016-12-20 | Orbusneich Medical, Inc. | Medical device with coating for capturing genetically-altered cells and methods for using same |
| US8088060B2 (en) | 2000-03-15 | 2012-01-03 | Orbusneich Medical, Inc. | Progenitor endothelial cell capturing with a drug eluting implantable medical device |
| BR0207297A (pt) | 2001-02-15 | 2005-04-19 | King Pharmaceuticals Inc | Composição farmacêutica em forma sólida e método de preparar uma forma de dosagem sólida de um ingrediente farmaceuticamente ativo |
| US6555581B1 (en) | 2001-02-15 | 2003-04-29 | Jones Pharma, Inc. | Levothyroxine compositions and methods |
| US20030194436A1 (en) * | 2001-08-10 | 2003-10-16 | Franz Andrew G. | Immediate release pharmaceutical compositions |
| US20030199585A1 (en) * | 2001-08-10 | 2003-10-23 | Franz G Andrew | Levothyroxine compositions and methods |
| US20030195254A1 (en) * | 2001-08-14 | 2003-10-16 | Franz G. Andrew | Levothyroxine compositions having unique triiodothyronine Tmax properties |
| US7101569B2 (en) | 2001-08-14 | 2006-09-05 | Franz G Andrew | Methods of administering levothyroxine pharmaceutical compositions |
| US20030099699A1 (en) * | 2001-11-13 | 2003-05-29 | Hanshew Dwight D. | Storage stable thyroxine active drug formulations and methods for their production |
| US7192657B2 (en) * | 2003-04-15 | 2007-03-20 | 3M Innovative Properties Company | Ethynyl containing electron transport dyes and compositions |
| MX2007007860A (es) * | 2004-12-27 | 2007-07-18 | King Pharmaceuticals Res & Dev | Envase impermeable al oxigeno con composiciones de la hormona tiroidea estabilizadas, secuestrante de oxigeno opcional, y metodos para el almacenamiento de composiciones farmaceuticas de la hormona tiroidea. |
| US7858663B1 (en) | 2007-10-31 | 2010-12-28 | Pisgah Laboratories, Inc. | Physical and chemical properties of thyroid hormone organic acid addition salts |
| US20150017236A1 (en) * | 2013-07-09 | 2015-01-15 | Jefferson J. Gregory | Pharmaceutical compositions of thyroid hormone |
| WO2018069805A2 (en) | 2016-10-10 | 2018-04-19 | Ftf Pharma Private Limited | Method for preparation of liquid oral composition of l-thyroxin |
| DE102017122807B4 (de) | 2017-09-29 | 2023-02-09 | Berlin-Chemie Ag | Orales Schilddrüsentherapeutikum |
| PT3576795T (pt) | 2017-02-03 | 2021-06-22 | Berlin Chemie Ag | Agente terapêutico oral para a tiroide |
| KR20240039868A (ko) * | 2022-09-20 | 2024-03-27 | 한국유나이티드제약 주식회사 | 갑상선 보호용 약학조성물 및 이의 제조방법 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5225204A (en) | 1991-11-05 | 1993-07-06 | Chen Jivn Ren | Stable dosage of levothyroxine sodium and process of production |
| DE19541128C2 (de) * | 1995-10-27 | 1997-11-27 | Henning Berlin Gmbh & Co | Stabilisierte schilddrüsenhormonhaltige Arzneimittel |
| US5635209A (en) * | 1995-10-31 | 1997-06-03 | Vintage Pharmaceuticals, Inc. | Stabilized composition of levothyroxine sodium medication and method for its production |
| PT861073E (pt) * | 1995-11-14 | 2004-10-29 | Abbott Gmbh & Co Kg | Preparacoes de hormona da tiroide estabilizadas e metodos para prepara-las |
| HUT75956A (en) * | 1995-11-29 | 1997-05-28 | Cyclolab | Pharmaceutical composition containing thyroxine |
-
1998
- 1998-07-07 DE DE19830246A patent/DE19830246A1/de not_active Withdrawn
-
1999
- 1999-06-29 WO PCT/EP1999/004485 patent/WO2000002586A1/de active IP Right Grant
- 1999-06-29 AU AU47793/99A patent/AU751575B2/en not_active Ceased
- 1999-06-29 CZ CZ20010074A patent/CZ296897B6/cs not_active IP Right Cessation
- 1999-06-29 US US09/743,114 patent/US6491946B1/en not_active Expired - Fee Related
- 1999-06-29 PL PL99344834A patent/PL344834A1/xx unknown
- 1999-06-29 DE DE59910298T patent/DE59910298D1/de not_active Expired - Lifetime
- 1999-06-29 HU HU0104985A patent/HUP0104985A3/hu unknown
- 1999-06-29 CN CN99808077A patent/CN1307486A/zh active Pending
- 1999-06-29 SK SK2004-2000A patent/SK20042000A3/sk unknown
- 1999-06-29 JP JP2000558845A patent/JP2002520296A/ja active Pending
- 1999-06-29 BR BR9911884-0A patent/BR9911884A/pt not_active IP Right Cessation
- 1999-06-29 EP EP99931209A patent/EP1094841B1/de not_active Expired - Lifetime
- 1999-06-29 CA CA002336748A patent/CA2336748A1/en not_active Abandoned
- 1999-06-29 ID IDW20010180A patent/ID27150A/id unknown
- 1999-06-29 KR KR1020017000222A patent/KR20010071765A/ko not_active Ceased
- 1999-06-29 AT AT99931209T patent/ATE273697T1/de active
- 1999-07-07 AR ARP990103299A patent/AR019899A1/es not_active Application Discontinuation
-
2001
- 2001-01-05 NO NO20010089A patent/NO20010089L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1094841B1 (de) | 2004-08-18 |
| DE59910298D1 (de) | 2004-09-23 |
| EP1094841A1 (de) | 2001-05-02 |
| CA2336748A1 (en) | 2000-01-20 |
| ID27150A (id) | 2001-03-08 |
| BR9911884A (pt) | 2001-03-27 |
| AU751575B2 (en) | 2002-08-22 |
| HUP0104985A2 (hu) | 2002-04-29 |
| SK20042000A3 (sk) | 2001-09-11 |
| ATE273697T1 (de) | 2004-09-15 |
| HUP0104985A3 (en) | 2003-03-28 |
| PL344834A1 (en) | 2001-11-19 |
| NO20010089D0 (no) | 2001-01-05 |
| CZ200174A3 (en) | 2001-05-16 |
| KR20010071765A (ko) | 2001-07-31 |
| DE19830246A1 (de) | 2000-01-13 |
| US6491946B1 (en) | 2002-12-10 |
| CZ296897B6 (cs) | 2006-07-12 |
| WO2000002586A1 (de) | 2000-01-20 |
| JP2002520296A (ja) | 2002-07-09 |
| AU4779399A (en) | 2000-02-01 |
| AR019899A1 (es) | 2002-03-20 |
| CN1307486A (zh) | 2001-08-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20010089L (no) | Farmasöytisk levotyroksinpreparat | |
| ES2165833T1 (es) | Composicion farmaceutica revestida enterica y procedimiento de fabricacion. | |
| FI20011852A7 (fi) | Menetelmä fluoksetiinia tai sen happoadditiosuolaa sisältävän dispergoituvan tabletin valmistamiseksi | |
| HUP9802086A2 (hu) | Piperidino-alkanol vegyületeket tartalmazó gyógyszerkészítmények | |
| AR003476A1 (es) | Tabletas exentas de aglutinante que contienen tramadol o una sal de tramadol | |
| EA200000245A1 (ru) | Быстро дезинтегрирующие таблетки метилцеллюлозы | |
| MX9705383A (es) | Compuesto que tienen efectos sobre los sistemas relacionados con la serotonina. | |
| PT1305286E (pt) | Ciclopentanoindoles composicoes que contem os referidos compostos e metodos de tratamento | |
| NO941358L (no) | Vandig farmasöytisk suspensjon og fremgangsmåte for fremstilling derav | |
| YU56995A (sh) | Soli derivata indola | |
| UA66750C2 (en) | Substituted 1-phenylpirazole 3-carboxamides, a method for the preparation thereof and intermediary compounds, pharmaceutical composition having affinity to neurotensin receptors | |
| RU2008143545A (ru) | Применение антагониста рецептора ат-1 или модулятора рецептора ат-2 для лечения болезней, связанных с увеличением содержания рецепторов ат-1 или ат-2 | |
| ES2184881T3 (es) | Composicion farmaceutica de ester etilico de l-dopa. | |
| FI962445A7 (fi) | Paroksetiinitabletteja ja menetelmä niiden valmistamiseksi | |
| NO20014101L (no) | Stabilisert oral farmasöytisk blanding inneholdende iodid og iodat og fremgangsmåte | |
| PT1414816E (pt) | Polimorfo estavel da flibanserina, processo tecnico para a sua preparacao e sua utilizacao na preparacao de medicamentos | |
| FI980862A0 (fi) | Kiraalisia metyylifenyylioksatsolidinoneja | |
| MY120570A (en) | Pharmaceutical preparation containing levothyroxine sodium | |
| DE69513254D1 (de) | Gepirone enthaltende Zusammensetzungen | |
| TR200000148T2 (tr) | 1-(4-Karbazoliloksi)-3-(2-metoksifenoksi) etilamino)-2-propanol' ün modifikasyonu, gerekli proses ve farmasötik bileşimler. | |
| DE60112956T2 (de) | Kristalline formen von fluvastatin sodium | |
| MY140127A (en) | Pharmaceutical formulation | |
| SE8901003L (sv) | Snabbloesliga preparat | |
| SE8401201L (sv) | Farmaceutisk beredning | |
| PT90661A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo inibidores da enzima conversora de angiotensina e moduladores de canal de potassio |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |